Concepedia

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

Salim Yusuf, Marc A. Pfeffer, Karl Swedberg, Christopher B. Granger, Peter Held, John J.V. McMurray, Eric L. Michelson, Bertil Olofsson, Jan Östergren

The Lancet · 2003 · 3K citations · 19 references

DOI

Concepts

References

19

Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients

New England Journal of Medicine · 2000 · 8.7K citations · Full text

, , +16

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

Björn Dahlöf, Richard B. Devereux, Sverre E. Kjeldsen et al. · The Lancet · 2002 · 5.4K citations

, , +13

A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure

Jay N. Cohn, Gianni Tognoni · New England Journal of Medicine · 2001 · 3.1K citations · Full text

, , +13

Effect of Carvedilol on Survival in Severe Chronic Heart Failure

Milton Packer, Andrew J.S. Coats, Michael B. Fowler et al. · New England Journal of Medicine · 2001 · 3.1K citations · Full text

, , +11

The Effect of Digoxin on Mortality and Morbidity in Patients with Heart Failure

The Digitalis Investigation Group · New England Journal of Medicine · 1997 · 3K citations · Full text

, , +12